Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.24.3
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Pre-funded warrants
Common Stock
Pre-funded warrants
Additional Paid-In Capital
Pre-funded warrants
Preferred Stock
Series E-2 Preferred Stock
Preferred Stock
Series E-3 preferred stock
Preferred Stock
Series E-4 preferred stock
Preferred Stock
Common Stock
Series E-2 Preferred Stock
Common Stock
Series E-3 preferred stock
Common Stock
Series E-4 preferred stock
Common Stock
Additional Paid-In Capital
Series E-2 Preferred Stock
Additional Paid-In Capital
Series E-3 preferred stock
Additional Paid-In Capital
Series E-4 preferred stock
Additional Paid-In Capital
Accumulated Deficit
Series E-1 preferred stock
Series E-4 preferred stock
Series D preferred stock
Total
Balance beginning at Dec. 31, 2022                     $ 94       $ 168,143,557 $ (159,990,407)       $ 8,153,244
Balance beginning (in shares) at Dec. 31, 2022                     9,385,272                  
Increase (Decrease) in Stockholders' Equity (Deficit)                                        
Stock-based compensation                             408,206         408,206
Conversion of preferred stock to common stock $ 3   $ 3                                  
Conversion of preferred stock to common stock (in shares) 355,235                                      
Net loss                               (7,190,470)       (7,190,470)
Balance ending at Mar. 31, 2023                     $ 97       168,551,763 (167,180,877)       1,370,983
Balance ending (in shares) at Mar. 31, 2023                     9,740,507                  
Balance beginning Series D preferred stock at Dec. 31, 2022                                     $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2022                                     111.11  
Balance ending Series D preferred stock at Mar. 31, 2023                                     $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Mar. 31, 2023                                     111.11  
Balance beginning at Dec. 31, 2022                     $ 94       168,143,557 (159,990,407)       8,153,244
Balance beginning (in shares) at Dec. 31, 2022                     9,385,272                  
Increase (Decrease) in Stockholders' Equity (Deficit)                                        
Net loss                                       (34,889,488)
Balance ending at Sep. 30, 2023                     $ 99       166,879,534 (194,879,895)       (28,000,262)
Balance ending (in shares) at Sep. 30, 2023                     9,918,384                  
Balance beginning Series D preferred stock at Dec. 31, 2022                                     $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2022                                     111.11  
Balance ending Series D preferred stock at Sep. 30, 2023                                     $ 19,202,023  
Balance ending Series D preferred stock (in shares) at Sep. 30, 2023                                     1,336.11  
Balance beginning at Mar. 31, 2023                     $ 97       168,551,763 (167,180,877)       1,370,983
Balance beginning (in shares) at Mar. 31, 2023                     9,740,507                  
Increase (Decrease) in Stockholders' Equity (Deficit)                                        
Stock-based compensation                             419,757         419,757
Net loss                               (10,178,640)       (10,178,640)
Balance ending at Jun. 30, 2023                     $ 97       168,971,520 (177,359,517)       (8,387,900)
Balance ending (in shares) at Jun. 30, 2023                     9,740,507                  
Balance beginning Series D preferred stock at Mar. 31, 2023                                     $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Mar. 31, 2023                                     111.11  
Balance ending Series D preferred stock at Jun. 30, 2023                                     $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Jun. 30, 2023                                     111.11  
Increase (Decrease) in Stockholders' Equity (Deficit)                                        
Stock-based compensation                             497,878         497,878
Issuance of preferred stock, net of issuance costs                                 $ 17,820,000      
Issuance of preferred stock, net of issuance costs (in shares)                                 1,225.00      
Exercise of warrants into common shares                     $ 2       649,248         649,250
Exercise of warrants into common shares (in shares)                     177,877                  
Net loss                               (17,520,378)       (17,520,378)
Balance ending at Sep. 30, 2023                     $ 99       166,879,534 (194,879,895)       (28,000,262)
Balance ending (in shares) at Sep. 30, 2023                     9,918,384                  
Balance ending Series D preferred stock at Sep. 30, 2023                                     $ 19,202,023  
Balance ending Series D preferred stock (in shares) at Sep. 30, 2023                                     1,336.11  
Increase (Decrease) in Convertible Preferred Stock                                        
Reclassification of pre-funded warrants to liability liability                             (3,239,112)         (3,239,112)
Balance beginning at Dec. 31, 2023             $ 4,677,632       $ 207       182,924,210 (202,761,017)       (15,158,968)
Balance beginning (in shares) at Dec. 31, 2023             319.76       20,744,110                  
Increase (Decrease) in Stockholders' Equity (Deficit)                                        
Stock-based compensation                             454,363         454,363
Conversion of preferred stock to common stock $ 11 $ 3,972,529 $ 3,972,540 $ (1,203,346) $ (33,983,571)     $ 9 $ 100     $ 1,203,337 $ 33,983,471              
Conversion of preferred stock to common stock (in shares) 1,079,132     82.26 (1,575.00)     903,956 9,890,099                      
Exercise of warrants for preferred stock, net of issuance costs (Note 2)             $ 47,577,000                         47,577,000
Exercise of warrants for preferred stock, net of issuance costs (Note 2) (in shares)             2,205.00                          
Exercise of warrants into common shares                     $ 5       2,298,138         2,298,143
Exercise of warrants into common shares (in shares)                     547,177                  
Retired shares (in shares)                     (8)                  
Net loss                               (26,641,983)       (26,641,983)
Balance ending at Mar. 31, 2024             $ 17,067,715       $ 332       224,836,048 (229,403,000)       12,501,095
Balance ending (in shares) at Mar. 31, 2024             867.50       33,164,466                  
Balance beginning Series D preferred stock at Dec. 31, 2023                                     $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2023                                     111.11  
Balance ending Series D preferred stock at Mar. 31, 2024                                     $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Mar. 31, 2024                                     111.11  
Balance beginning at Dec. 31, 2023             $ 4,677,632       $ 207       182,924,210 (202,761,017)       (15,158,968)
Balance beginning (in shares) at Dec. 31, 2023             319.76       20,744,110                  
Increase (Decrease) in Stockholders' Equity (Deficit)                                        
Net loss                                       (42,226,073)
Balance ending at Sep. 30, 2024             $ 13,615,544       $ 406       246,536,080 (244,987,090)       15,164,940
Balance ending (in shares) at Sep. 30, 2024             1,066.10       40,566,534                  
Balance beginning Series D preferred stock at Dec. 31, 2023                                     $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Dec. 31, 2023                                     111.11  
Balance ending Series D preferred stock at Sep. 30, 2024                                     $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Sep. 30, 2024                                     111.11  
Balance beginning at Mar. 31, 2024             $ 17,067,715       $ 332       224,836,048 (229,403,000)       12,501,095
Balance beginning (in shares) at Mar. 31, 2024             867.50       33,164,466                  
Increase (Decrease) in Stockholders' Equity (Deficit)                                        
Stock-based compensation                             799,249         799,249
Conversion of preferred stock to common stock         $ (9,224,112)       $ 26       $ 9,224,086              
Conversion of preferred stock to common stock (in shares)         (427.50)       2,684,458                      
Net loss                               (919,371)       (919,371)
Balance ending at Jun. 30, 2024             $ 7,843,603       $ 358       234,859,383 (230,322,371)       12,380,973
Balance ending (in shares) at Jun. 30, 2024             440.00       35,848,924                  
Balance beginning Series D preferred stock at Mar. 31, 2024                                     $ 1,382,023  
Balance beginning Series D preferred stock (in shares) at Mar. 31, 2024                                     111.11  
Balance ending Series D preferred stock at Jun. 30, 2024                                     $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Jun. 30, 2024                                     111.11  
Increase (Decrease) in Stockholders' Equity (Deficit)                                        
Stock-based compensation                             1,534,054         1,534,054
Issuance of preferred stock, net of issuance costs           $ 15,914,632                       $ 15,914,632    
Issuance of preferred stock, net of issuance costs (in shares)           1,610.00                            
Conversion of preferred stock to common stock       $ (1,285,851)   $ (8,856,840)   $ 10   $ 38   $ 1,285,841   $ 8,856,802            
Conversion of preferred stock to common stock (in shares)       (87.90)   (896.00)   965,934   3,750,909                    
Stock option exercise into common stock (in shares)                     767                  
Net loss                               (14,664,719)       (14,664,719)
Balance ending at Sep. 30, 2024             $ 13,615,544       $ 406       $ 246,536,080 $ (244,987,090)       $ 15,164,940
Balance ending (in shares) at Sep. 30, 2024             1,066.10       40,566,534                  
Balance ending Series D preferred stock at Sep. 30, 2024                                     $ 1,382,023  
Balance ending Series D preferred stock (in shares) at Sep. 30, 2024                                     111.11